Mirion Technologies Announces Earnings Release and Conference Call Date for Fourth Quarter and Fiscal Year 2022 Results
Mirion Technologies, Inc. (NYSE:MIR) ("Mirion") ("Company") announced today that it will release its financial results for the fourth quarter and fiscal year 2022 on Tuesday, February 14, 2023. Following the news
Scripps Health Radiation Therapy Centers Named Patient Safety Center of Excellence by Sun Nuclear
Designation Recognizes Partnership for Improved Quality Management and Enhanced Patient Care in Radiation Therapy MELBOURNE, Fla., Jan. 26, 2023 /PRNewswire/ -- Sun Nuclear, a wholly-owned subsidiary of Mirion
(SPAC) Special Purpose Acquisition Investigation: TTCF, LVOX, SUNL, MIR, Contact Shareholder Rights Law Firm Johnson Fistel
SAN DIEGO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies
(SPAC) Special Purpose Acquisition Investigation: IONQ, LVOX, MTTR, MIR, Contact Shareholder Rights Law Firm Johnson Fistel
SAN DIEGO, Jan. 14, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of law in connection with the following special purpose acquisition companies
Are Investors Undervaluing Mirion Technologies, Inc. (NYSE:MIR) By 47%?
Is Mirion Technologies (MIR) a Worthy Investment?
Mirion Technologies to Present at the CJS Securities 23rd Annual New Ideas for the New Year Conference
ATLANTA--(BUSINESS WIRE)--Mirion Technologies, Inc. (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at the CJS Securit
MedMira Provides Progress Update
07:20 AM EST, 01/04/2023 (MT Newswires) -- MedMira Inc. (MIR.V) overnight Tuesday announced the publication of "Point-of-Care Diagnostic for Trichomonas vaginalis, the Most Prevalent, Non-viral Sexual
MedMira Reports Wider Fiscal Q1 Loss, Lower Revenue
09:06 AM EST, 01/03/2023 (MT Newswires) -- MedMira Inc. (MIR.TO), a developer and manufacturer of Rapid Vertical Flow Technology diagnostics, over the New Year holiday weekend reported a fiscal first-
MedMira Introduces New Product In Direct Response to Rise of Respiratory Syncytial Virus Cases Globally
08:17 AM EST, 12/30/2022 (MT Newswires) -- MedMira Inc. (MIR.TO), a developer and manufacturer of Rapid Vertical Flow Technology diagnostics, overnight Thursday announced its latest addition to the VY
Loading...
No Stock Yet